Panbela Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Panbela Therapeutics

10/11/2021 23:45

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted loss of 16 cents​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 23 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Panbela Therapeutics Inc's reported EPS for the quarter was a
loss of 16 cents​.
* The mean earnings estimate of analysts had fallen by
about 21.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Panbela Therapeutics Inc shares had fallen by 3.7% this
quarter and lost 41.3% so far this year.
* The company reported a quarterly loss of $2.14 million.
* Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 11:44 p.m.
 ​All figures in US dollars unless otherwise stated